首页> 外文期刊>Neuroscience: An International Journal under the Editorial Direction of IBRO >Paradoxical activational effects of a corticotropin-releasing factor-binding protein 'ligand inhibitor' in rat brain.
【24h】

Paradoxical activational effects of a corticotropin-releasing factor-binding protein 'ligand inhibitor' in rat brain.

机译:促肾上腺皮质激素释放因子结合蛋白“配体抑制剂”在大鼠脑中的反常激活作用。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The corticotropin-releasing factor-binding protein is distinct from known corticotropin-releasing factor receptors, but can bind the peptide and neutralize its biological actions. Recent interest has centered about the therapeutic potential of "ligand inhibitors" of binding protein action, synthetic corticotropin-releasing factor fragments which are inactive at corticotropin-releasing factor receptors, but can displace the peptide from the binding protein, thereby increasing levels of free corticotropin-releasing factor. To identify sites of action of such ligands, the distribution of Fos expression seen following intracerebroventricular administration of rat/human corticotropin-releasing factor(6-33) (5-50 microg) was charted in relation to corticotropin-releasing factor-binding protein and receptor expression. It was expected that Fos induction would mimic aspects of the distribution of the two known corticotropin-releasing factor receptors, but the far greater correspondence was seen with that of the binding protein itself. This included neurons in the isocortex, the olfactory system, amygdala and a number of discrete brainstem cell groups; many Fos-immunoreactive neurons in each were found to co-express corticotropin-releasing factor-binding protein messenger RNA. Subsets of activated neurons co-expressed Type 1 corticotropin-releasing factor receptor messenger RNA, though these were largely limited to cell groups that also express the corticotropin-releasing factor-binding protein, and where binding protein immunoreactivity and Type 1 receptor transcripts were found to co-exist. Responsive neurons displaying Type 2 corticotropin-releasing factor receptor message were seen reliably only in the lateral septal nucleus.These findings support only a limited capacity of the ligand inhibitor to activate neurons bearing corticotropin-releasing factor receptors. The more pervasive activation seen among neurons that express the corticotropin-releasing factor-binding protein may be indicative of an unexpected role for this protein in signaling by corticotropin-releasing factor-related peptides.
机译:促肾上腺皮质激素释放因子结合蛋白不同于已知的促肾上腺皮质激素释放因子受体,但可以结合该肽并中和其生物学作用。最近的兴趣集中在结合蛋白作用的“配体抑制剂”的治疗潜力,合成的促肾上腺皮质激素释放因子片段上,该片段在促肾上腺皮质激素释放因子受体上没有活性,但是可以从结合蛋白上置换肽,从而增加游离促肾上腺皮质激素的水平释放因子。为了确定此类配体的作用位点,绘制了脑室内给予大鼠/人促肾上腺皮质激素释放因子(6-33)(5-50 microg)后所见到的Fos表达与促肾上腺皮质激素释放因子结合蛋白及受体表达。预期Fos的诱导将模拟两个已知的促肾上腺皮质激素释放因子受体分布的各个方面,但与结合蛋白本身的对应关系则要大得多。这包括等皮质,嗅觉系统,杏仁核和许多离散的脑干细胞群中的神经元。发现每个中的许多Fos免疫反应神经元共同表达促肾上腺皮质激素释放因子结合蛋白信使RNA。活化神经元的亚群共表达1型促肾上腺皮质激素释放因子受体信使RNA,尽管这些亚组主要限于也表达促肾上腺皮质激素释放因子结合蛋白的细胞群,并且发现结合蛋白的免疫反应性和1型受体转录本共存。仅在外侧中隔核中才能可靠地看到显示2型促肾上腺皮质激素释放因子受体信息的反应性神经元,这些发现仅支持配体抑制剂激活携带促肾上腺皮质激素释放因子受体神经元的能力有限。在表达促肾上腺皮质激素释放因子结合蛋白的神经元中看到的更普遍的激活可能表明该蛋白在促肾上腺皮质激素释放因子相关肽的信号传导中具有意想不到的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号